Study of Breast Lump, a Histopathological Audit of FIVE Years Specimen in a Medical College
Keywords:
breast lump, carcinoma, fibroadenoma, biopsy
Abstract
Background: Various types of lesion from inflammation to carcinoma can affect the breast. Some lesions are common in young females while others are more common in elderly age group. Early presentation and prompt diagnosis is essential to relieve anxiety of non-neoplastic conditions, and in casse of carcinoma, it can save the patient from metastases. Methods: A Retrospective study was conducted for the period of five years in the Pathology Department of Jahurul Islam Medical College and Hospital. Histopathology samples were received, processed, reported and recorded in the Pathology laboratory. Data analysed from 2012 to 2016. Descriptive statistics was used to analyse the data. Result: 228 sample of breast tissue sent for histopathology were studied. Peak incidence of benign lesion was in between 21-30 years and malignant lesions in between 31-50 years. No breast lesions were seen in the first decade of life. Cancer of the breast was seen in 12.28% of cases. Fibroadenoma and fibrocystic disease were the commonest benign lesion and infiltrating ductal carcinoma was the commonest malignant lesion. Conclusion: Majority of the breast lumps are benign either fibroadenoma or fibrocystic disease. Benign lesions were common in second to fourth decade and malignancy in fourth and fifth decades.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2017-01-15
Issue
Section
License
Copyright (c) 2017 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.